lobbying_activities: 516400

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
516400	17f23e5f-63bf-4a0a-b055-12fb0ab81cec	MM	WALGREEN COMPANY	309071	WALGREEN COMPANY	2007	mid_year	PHA	S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		500000	0	0	2007-08-08T22:24:30-04:00